How May LUCENTIS Help People With mCNV?

LUCENTIS may help people with mCNV see more letters on an eye chart

In a 3-month study of 276 people with mCNV:

2 groups of patients received LUCENTIS (222 patients total), and 55 patients did not receive LUCENTIS

2 groups of patients received LUCENTIS (222 patients total), and 55 patients did not receive LUCENTIS

LUCENTIS may help improve* vision in people with mCNV

*Improvement is defined as the ability to see 15 or more letters on an eye chart.

In the same 3-month study:

LUCENTIS


37% to 40% of people saw an improvement*

NO LUCENTIS


Nearly 15% of people saw an improvement

*This means they were able to see 15 or more letters on an eye chart.


How often will I need a LUCENTIS treatment?

Your doctor will decide how often you need LUCENTIS treatments. Monthly treatments are recommended for up to 3 months.

In a study of 222 patients treated with LUCENTIS, 2 out of 5 people (41%) with mCNV had 1, 2, or 3 injections over the course of 3 months and received no injections thereafter.


Financial Assistance Options

Financial Assistance Options

There may be options to help you afford LUCENTIS, no matter what type of health insurance you have. Learn about Genentech Access Solutions.

Who is LUCENTIS for? LUCENTIS® is a prescription medicine for the treatment of patients with myopic choroidal neovascularization (mCNV).

What important safety information should I know about LUCENTIS? You should not use LUCENTIS if you have an infection in or around the eye or are allergic to LUCENTIS or any of its ingredients. LUCENTIS is a prescription medication given by injection into the eye, and it has side effects. LUCENTIS is not for everyone. Some LUCENTIS patients have had detached retinas and serious eye infections. If your eye becomes red, sensitive to light, or painful, or if you have a change in vision, call or visit your eye doctor right away. 

Some patients have had increased eye pressure before and within 1 hour of an injection. Your eye doctor should check your eye pressure and eye health before and after your LUCENTIS injection. 

Uncommonly, LUCENTIS patients have had serious, sometimes fatal, problems related to blood clots, such as heart attacks or strokes. 

Some LUCENTIS patients have serious side effects related to the injection. These include serious infections inside the eye, detached retinas, and cataracts. The most common eye-related side effects are increased redness in the white of the eye, eye pain, small specks in vision, and increased eye pressure. The most common non–eye-related side effects are nose and throat infections, anemia, nausea and cough. 

LUCENTIS is for prescription use only. 

You may report side effects to the FDA at (800) FDA-1088 or www.fda.gov/medwatch. You may also report side effects to Genentech at (888) 835-2555.

For additional Safety Information, please talk to your doctor and see the LUCENTIS full Prescribing Information.